Successful treatment with rituximab for autoimmune cytopenia after autologous hematopoietic stem cell transplantation

Pediatr Int. 2022 Jan;64(1):e14975. doi: 10.1111/ped.14975.

Authors

Mariko Kinoshita¹, Ai Yamada¹, Yusuke Saito¹, Sachiyo Kamimura¹, Hiroshi Moritake¹

Affiliation

¹ Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

PMID: 35139246
DOI: 10.1111/ped.14975

No abstract available

Keywords: autoimmune cytopenia; autologous hematopoietic stem cell transplantation; neuroblastoma; rituximab.

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Leukopenia*
Rituximab / therapeutic use
Thrombocytopenia*
Transplantation, Autologous

Substances

Rituximab